A single use, self-administered, dissolving microneedle array for site specific pain relief without the need of a healthcare professional. The sharps-free microneedle array provides rapid intradermal delivery without pain, bleeding, or bruising. A modified version is currently used by CDC, NIH, and UNICEF for vaccines in developing countries.
Primary Application Area: Biotech, Pharma, Health
Technology Development Status: Proven Manufacturability
Technology Readiness Level: TRL 6
Vetted Programs/Awards: Isosceles was awarded first prize in the North Carolina Biotech Venture Challenge and received $20,000 grant for top prize. Isosceles has also won awards from business journals and non-profits.
Organization Type: Mid-stage Startup (A or B)
Showcase Booth: 525T
Market Keywords: Anti-inflammatory, Nonopioid pain relief, Medically Underserved Areas